Amgen, Janssen team up in trial collaboration for myeloma
Janssen Biotech Inc. and Amgen Inc.'s Onyx Pharmaceuticals Inc. entered into a trial collaboration agreement to evaluate the efficacy and safety of Janssen's Darzalex (daratumumab) in combination with Onyx's Kyprolis carfilzomib and dexamethasone as a treatment for cancer.
- Trial Collaborations
- R&D (No Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com